Compare Stocks → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ETXNASDAQ:PMNNYSEARCA:SBM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeETXEaton Vance Municipal Income 2028 Term Trust$17.84-1.2%$17.97$16.36▼$18.60N/AN/A28,886 shs53,454 shsPMNProMIS Neurosciences$1.91+9.1%$2.01$0.95▼$8.95$36.08M0.6844,670 shs9,199 shsSBMProShares Short Basic Materials$46.38$46.38$42.85▼$55.15$1.86MN/A3,024 shsN/AThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceETXEaton Vance Municipal Income 2028 Term Trust-1.16%-2.25%+0.39%+2.88%+0.90%PMNProMIS Neurosciences+9.14%-0.07%-7.73%+66.09%-60.04%SBMProShares Short Basic Materials0.00%0.00%0.00%0.00%-0.01%Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationETXEaton Vance Municipal Income 2028 Term TrustN/AN/AN/AN/AN/AN/AN/AN/APMNProMIS Neurosciences2.3366 of 5 stars3.53.00.00.02.41.70.6SBMProShares Short Basic MaterialsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceETXEaton Vance Municipal Income 2028 Term TrustN/AN/AN/AN/APMNProMIS Neurosciences3.00Buy$8.00318.85% UpsideSBMProShares Short Basic Materials0.00N/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookETXEaton Vance Municipal Income 2028 Term Trust$-232.48KN/AN/AN/AN/AN/APMNProMIS Neurosciences$10K3,607.99N/AN/A($0.16) per share-11.94SBMProShares Short Basic MaterialsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateETXEaton Vance Municipal Income 2028 Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/APMNProMIS Neurosciences-$18.06M-$1.94N/AN/AN/AN/AN/A-219.98%4/3/2024 (Estimated)SBMProShares Short Basic MaterialsN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthETXEaton Vance Municipal Income 2028 Term Trust$0.764.26%N/AN/AN/APMNProMIS NeurosciencesN/AN/AN/AN/AN/ASBMProShares Short Basic MaterialsN/AN/AN/AN/AN/ALatest SBM, IMM, PMN, ETX, and OBD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/1/2024ETXEaton Vance Municipal Income 2028 Term Trustmonthly$0.07825.2%3/20/20243/21/20243/28/20242/1/2024ETXEaton Vance Municipal Income 2028 Term Trustmonthly$0.07825.3%2/21/20242/22/20242/29/20241/2/2024ETXEaton Vance Municipal Income 2028 Term TrustMonthly$0.07805.34%1/22/20241/23/20241/31/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioETXEaton Vance Municipal Income 2028 Term TrustN/AN/AN/APMNProMIS NeurosciencesN/A1.811.81SBMProShares Short Basic MaterialsN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipETXEaton Vance Municipal Income 2028 Term TrustN/APMNProMIS Neurosciences50.13%SBMProShares Short Basic MaterialsN/AInsider OwnershipCompanyInsider OwnershipETXEaton Vance Municipal Income 2028 Term TrustN/APMNProMIS Neurosciences10.30%SBMProShares Short Basic MaterialsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableETXEaton Vance Municipal Income 2028 Term TrustN/AN/AN/ANot OptionablePMNProMIS Neurosciences618.89 million16.94 millionNot OptionableSBMProShares Short Basic MaterialsN/A40,000N/ANot OptionableSBM, IMM, PMN, ETX, and OBD HeadlinesSourceHeadlineFundamentals of Materials for Energy and Environmental Sustainabilitycambridge.org - March 24 at 5:46 PMSh4b set aside for CBC classrooms missingstandardmedia.co.ke - February 25 at 10:22 PMTTT ProShares UltraPro Short 20+ Year Treasury ETFseekingalpha.com - December 24 at 6:36 PMProShares Short Basic Materials (SBM)finance.yahoo.com - November 23 at 7:46 AMAll Indicesthestreet.com - September 18 at 9:22 PMProShares Short Financials (SEF)investing.com - August 24 at 3:19 PMProShares Short Basic Materials Newsthestreet.com - August 23 at 11:58 PMVolatile Market Conditions Could Drive Investors to Tradeinvestopedia.com - July 23 at 10:52 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Your Comprehensive Guide to Investing in Bank StocksMarch 1, 2024 10:41 AMView Your Comprehensive Guide to Investing in Bank StocksAdobe Stock Reaches Turning Point as Market Outlook ResetsMarch 15, 2024 8:55 AMView Adobe Stock Reaches Turning Point as Market Outlook ResetsFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentAll Headlines Company DescriptionsEaton Vance Municipal Income 2028 Term TrustNYSE:ETXEaton Vance Municipal Income 2028 Term Trust is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. It invests in the fixed income markets. The fund invest in stocks of companies operating across the diversified sectors. It was previously known as Eaton Vance Municipal Income Term Trust. Eaton Vance Municipal Income 2028 Term Trust was formed on March 28, 2013 and is domiciled in the United States.ProMIS NeurosciencesNASDAQ:PMNProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.ProShares Short Basic MaterialsNYSEARCA:SBMProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.